Aripiprazole in Children With Autism: A Pilot Study
Status:
Completed
Trial end date:
2011-11-16
Target enrollment:
Participant gender:
Summary
This is a 6-week open pilot study of aripiprazole for the treatment of adolescents, aged 12
to 18 years, diagnosed with autism.
Children who qualify for the study will be treated with aripiprazole for 6 weeks.
Treatment is provided at no cost.